Yuuki Obata Selected Research

DNA (Deoxyribonucleic Acid)

9/2009

Bleomycin-induced over-replication involves sustained inhibition of mitotic entry through the ATM/ATR pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuuki Obata Research Topics

Disease

7	Neoplasms (Cancer) 04/2024 - 10/2009
3	Colitis 01/2021 - 03/2012
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2023 - 01/2023
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2019
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2021 - 01/2017
1	Hypoxia (Hypoxemia) 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Leukemia 01/2019
1	Melanoma (Melanoma, Malignant) 01/2017
1	Diarrhea 01/2017
1	Adenocarcinoma of Lung 07/2015
1	Hyperplasia 09/2013
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2013
1	Polyploidy 09/2009

Drug/Important Bio-Agent (IBA)

4	Phosphotransferases (Kinase)IBA 04/2024 - 01/2017
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2023 - 10/2009
2	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2023
2	Imatinib Mesylate (Gleevec)FDA Link 01/2023 - 01/2017
2	CateninsIBA 01/2022 - 09/2013
1	LigandsIBA 04/2024
1	tyrosine receptor (receptor, tyrosine)IBA 04/2024
1	N- (pyridine- 3- ylmethyl)- 5- (7- hydroxy- 2,6,8- trimethyl- 1,2,4a,5,6,7,8,8a- octahydronaphthalene- 1- yl)- 2- methylpenta- 2,4- dienamideIBA 04/2024
1	Brefeldin AIBA 04/2024
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023
1	Protein Kinase D2IBA 01/2023
1	Sunitinib (Sutent)FDA Link 01/2023
1	KynurenineIBA 01/2022
1	PolyaminesIBA 01/2021
1	Dextran SulfateIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	TAS-116IBA 01/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2019
1	LipidsIBA 01/2019
1	Interleukin-3 (Interleukin 3)IBA 01/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2017
1	TOR Serine-Threonine KinasesIBA 07/2015
1	ErbB Receptors (EGF Receptor)IBA 07/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2015
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 07/2015
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 07/2015
1	Histone Deacetylases (Histone Deacetylase)IBA 03/2015
1	Volatile Fatty AcidsIBA 12/2013
1	Butyrates (Butyrate)IBA 12/2013
1	Cadherins (E-Cadherin)IBA 09/2013
1	CytokinesIBA 01/2013
1	Notch ReceptorsIBA 03/2012
1	Transcription Factors (Transcription Factor)IBA 03/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2012
1	DNA (Deoxyribonucleic Acid)IBA 09/2009

Therapy/Procedure

2	Therapeutics 01/2023 - 01/2019